Evidence map›Paper›PMID 41699722›Full record

ArticleMolecular autism2026

Cholecystokinin upregulation in mPFC leads to social defeat-induced anxiety susceptibility in neuroligin 3 R451C knockin mice.

Yuzhen Fu, Yuke Xu, Huiyi Li, Kaipeng Jiang, Qun Yang, Zhiyuan Li, Jialin Chen, Yingwei Ju, Keying Xu, Hangtian Yan and 8 more

Abstract read
In one paragraph

Article in Molecular autism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yuzhen Fu *Institute of Brain Science, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China.
Yuke Xu *Institute of Brain Science, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China.
Huiyi LiInstitute of Brain Science, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China.
Kaipeng JiangInstitute of Brain Science, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China.
Qun YangInstitute of Brain Science, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China.
Zhiyuan LiInstitute of Brain Science, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China.
Jialin ChenInstitute of Brain Science, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China.
Yingwei JuInstitute of Brain Science, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China.
Keying XuInstitute of Brain Science, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China.
Hangtian YanInstitute of Brain Science, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China.
Jiali GeInstitute of Brain Science, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China.
Sien LiInstitute of Brain Science, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China.
Kexian YanInstitute of Brain Science, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China.
Wenjie DouInstitute of Brain Science, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China.
Xintai WangZhejiang Key Laboratory of Organ Development and Regeneration, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou, 311121, China.
Jianhong LuoLaboratory of Translational Psychiatry, Affiliated Mental Health Center & Hangzhou Seventh People's, School of Brain Science and Brain Medicine, Zhejiang University School of Medicine, Hangzhou, 310013, China.ORCID 0000-0001-7832-496X
Baoming LiInstitute of Brain Science, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China. bmli@hznu.edu.cn.ORCID 0009-0006-1554-9700
Wei CaoInstitute of Brain Science, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China. caowei@hznu.edu.cn.ORCID 0000-0001-6196-5680

Funding

Autism Research Special Fund of Zhejiang Foundation For Disabled Persons 2023002Ministry of Science and Technology of the People's Republic of China 2021ZD0201705National Natural Science Foundation of China 32471067
6 · The paper itself

Abstract

backgroundAnxiety is a prevalent and clinically debilitating comorbidity in autism spectrum disorder (ASD), yet its underlying neurobiological mechanisms remain incompletely elucidated. This study aimed to investigate the role of dysregulated cholecystokinin (CCK) signaling within the medial prefrontal cortex (mPFC) in mediating stress-induced anxiety susceptibility in ASD.

methodsUsing Neuroligin 3 R451C knockin (KI) mice, a genetically validated ASD model, we examined the developmental trajectory of CCK-expressing neurons in the mPFC through immunohistochemistry. Elevated plus maze tests were conducted to assess baseline anxiety and susceptibility to social defeat stress (SDS) across developmental stages. In vivo fiber photometry was employed to monitor SDS-induced mPFC CCK secretion dynamics. Functional manipulations included targeted knockdown and overexpression of Cck in mPFC excitatory neurons via viral-mediated gene transfer.

resultsWe demonstrate a developmental perturbation in CCK-expressing excitatory neurons within the mPFC: their density increases sharply in early postnatal life, stabilizes during adolescence, and typically declines in adulthood in wild-type (WT) mice, yet remains persistently elevated in adult KI counterparts. In line with this anomaly, adult WT mice exhibit greater resilience to social defeat stress (SDS) than their adolescent counterparts, whereas KI mice sustain heightened anxiety susceptibility throughout adulthood—despite showing no baseline anxiety. Remarkably, SDS elicits a rapid and exaggerated surge in mPFC CCK secretion in adult KI mice, whereas WT controls exhibit a delayed and blunted response. Targeted knockdown of Cck in mPFC excitatory neurons significantly ameliorates SDS-induced anxiety-like behaviors in adult KI mice, whereas Cck overexpression in adult WT animals recapitulates the anxiogenic phenotype. LIMITATIONS: All experiments were conducted in male mice. Given the well-documented sex differences in the prevalence of ASD and anxiety disorders, further studies are warranted to determine whether similar effects occur in females.

conclusionsThese findings implicate dysregulated CCK signaling within the mPFC as a mechanistic substrate for stress-induced anxiety in ASD, and provide a neurobiological framework for understanding the heightened affective vulnerability associated with this condition.

Indexed as

AnxietyCholecystokininNerve Tissue ProteinsNeuroliginsPrefrontal CortexSocial DefeatUp-RegulationAnimalsAutism Spectrum DisorderBehavior, AnimalCell Adhesion Molecules, NeuronalDisease Models, AnimalDisease SusceptibilityGene Knock-In TechniquesMaleMembrane ProteinsCell Adhesion Molecules, NeuronalCholecystokininMembrane ProteinsNerve Tissue Proteinsneuroligin 3NeuroliginsAnxiety susceptibilityAutism spectrum disordersCholecystokininMedial prefrontal cortexNeuroligin 3

Identifiers

PMID41699722
PMCPMC12961789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.